BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma
Clinical trial NCT00126646 · COMPLETED
Trial details
- NCT number
- NCT00126646
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2009-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.